SCM
Sarissa Capital Management Portfolio holdings
AUM
$154M
This Quarter Return
+2.79%
1 Year Return
-6.05%
3 Year Return
-7.91%
5 Year Return
+32.47%
10 Year Return
+262.41%
AUM
$432M
AUM Growth
+$432M
(+11%)
Cap. Flow
+$37.3M
Cap. Flow
% of AUM
8.63%
Top 10 Holdings %
Top 10 Hldgs %
99.98%
Holding
12
New
1
Increased
3
Reduced
2
Closed
1
Top Buys
| 1 |
SHPG
Shire pic
SHPG
|
$39.4M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$27.9M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
$26.5M |
| 4 |
AGN
Allergan plc
AGN
|
$14.6M |
Top Sells
| 1 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$62.8M |
| 2 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$7.42M |
| 3 |
AbbVie
ABBV
|
$846K |
Sector Composition
| 1 | Healthcare | 85.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biogen
BIIB
$19.4B
| $113M | 26.22% | 413,858 | – | – |
|
|
MDCO
2
DELISTED
Medicines Co
MDCO
| $63.3M | 14.65% | 1,922,000 | – | – |
|
3
Innoviva
INVA
$1.29B
| $61M | 14.12% | 3,660,705 | – | – |
|
|
AGN
4
DELISTED
Allergan plc
AGN
| $57.9M | 13.4% | 344,000 +86,700 | +34% | +$14.6M |
|
|
5
Ironwood Pharmaceuticals
IRWD
$214M
| $52M | 12.02% | 3,367,100 +1,717,100 | +104% | +$26.5M |
|
|
SHPG
6
DELISTED
Shire pic
SHPG
| $39.4M | 9.13% | +264,000 | New | +$39.4M |
|
|
ICPT
7
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $39.1M | 9.04% | 635,300 +453,000 | +248% | +$27.9M |
|
|
NVLN
8
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $3.59M | 0.83% | 1,025,000 | – | – |
|
|
ACHN
9
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $1.86M | 0.43% | 500,000 -2,000,000 | -80% | -$7.42M |
|
|
SEEL
10
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $587K | 0.14% | 1,447,906 | – | – |
|
|
11
AbbVie
ABBV
$372B
| $94K | 0.02% | 1,000 -9,000 | -90% | -$846K |
|
|
BIVV
12
DELISTED
Bioverativ Inc. Common Stock
BIVV
| – | – | -1,165,000 | Closed | -$62.8M |
|